New Delhi [India], January 11 (ANI/PNN): Gytree.com announced its first round of fundraising, led by Biocon s Kiran Mazumdar Shaw, Rainmatter Investments, Ajay Srinivasan former CEO of Aditya Birla Capital, Anubhuti Sharma of San Francisco-based Millie Clinic amongst others.
Get latest articles and stories on Business at LatestLY. Gytree.com announced its first round of fundraising, led by Biocon s Kiran Mazumdar Shaw, Rainmatter Investments, Ajay Srinivasan former CEO of Aditya Birla Capital, Anubhuti Sharma of San Francisco-based Millie Clinic amongst others. Business News | Kiran Mazumdar Shaw Leads Investment in Gytree.com - Women s Health Platform Founded by Shaili Chopra.
Planning a pharma future for Mauritius is necessary and achievable lexpress.mu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lexpress.mu Daily Mail and Mail on Sunday newspapers.
A new business intelligence report released by JCMR with
Global Antineoplastic Drugs Market Report has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are
Hoffmann-La Roche, Amgen, Bristol-Myers Squibb, Baxter Healthcare, Boehringer Ingelheim, Aspen Global, Bayer AG, Teva pharmaceutical Industries, Johnson & Johnson, Merc & Co., Pfize, Accord Healthcare, Genentech, Lundbeck, AbbVie
During the forecast period, the report also mentions the expected CAGR of the global market Antineoplastic Drugs